tekst 1

Log in

Guide for Authors


Reviewers should agree to review a manuscript only if they have expertise in the subject area adequate for accurate assessing and giving a constructive report. Reviews should be based on relevancy, integrity, scientific strength, potential interest, completeness, clarity, and ethics in the work reported in manuscript.

Reviewers are asked to provide detailed, constructive comments that will help the editors make a decision on publication and help the authors improve the manuscript. A key issue is whether the work has serious flaws that should preclude its publication, or whether additional experiments or data are required to support the conclusions. Where possible, reviewers should provide references to substantiate their comments.

1 The International Journal of Medical Reviews and Case Reports (Int J Med Rev Case Rep) criteria for publication, which reviewers should take into account:

  • The study presents the results of primary scientific research.
  • Reviewers should comment on the originality and importance of the study. If the research is unoriginal because related work has been published previously, reviewers are advised to give relevant references. Reviewers should notify the editor immediately if they find that any information in the manuscript is plagiarized or infringed.
  • Experiments, statistics, and other analyses are performed to a high technical standard and are described in sufficient detail.
  • The research must have been performed to a technical standard high enough to allow robust conclusions to be drawn from the data. Methods and reagents also must be described in sufficient detail to permit another researcher to reproduce the experiments described.
  • Conclusions are presented in an appropriate fashion and supported by the data.
  • The results must be interpreted appropriately, such that all conclusions are justified. However, authors may discuss possible explanations for their results as long as these are clearly identified as speculations or hypotheses, rather than as firm conclusions. Inappropriate interpretation of results is a justifiable reason for rejection.
  • The article is presented in an intelligible fashion and is written in standard English.
  • Int J Med Rev Case Rep does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. If the language of a paper is difficult to understand or includes many errors, we may reject it, or recommend authors seek independent editorial help before submitting a revision.
  • The research meets all applicable standards for the ethics of experimentation and research integrity.
  • The research must have been conducted to the highest ethical standards. Reviewers should notify the editor if they have any concerns about ethical aspects or misconduct in the research.

2 Confidentiality

The review process is strictly confidential and should be treated as such by reviewers. Reviewers should respect the confidentiality and not disclose the described information until the manuscript is published. They should not use the information for their own benefit or share with any other individual or organization. Reviewers should not attempt to contact the authors regarding the manuscript without permission of the editor.

3 Timely Review

Int J Med Rev Case Rep believes that an efficient editorial process that results in timely publication is valuable both to the authors and the scientific community.

4. Competing Interests

Reviewers should declare any potential conflict of interests and seek assistance from the editor regarding any uncertain conflicts. Examples of obvious competing interest are: 1) reviewer was or may have been a collaborators on other projects with the authors of the manuscript under review; 2) reviewer and authors are or may be direct competitors; 3) reviewer has or may have a known history of antipathy toward the author(s); or 4) reviewer might profit financially from the work described.


International Journal of Medical Reviews and Case Reports (Int J Med Rev Case Rep) is an open access, online international peer-reviewed medical journal that publishes medical reviews, case reports, short communications, videos and image cases on all aspects of medicine. 

The authors may send their manuscripts in English, French, Spanish and Italian language.

The journal's full text is available online at http://www.JournalMedicalReports.com. Int J Med Rev Case Rep is published quarterly. The following instructions follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (ICJME Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals).

Manuscripts are accepted for consideration with the understanding that they have been submitted solely to International Journal of Medical Reviews and Case Reports (Int J Med Rev Case Rep) and that they have not been previously published, either in whole or in part. Int J Med Rev Case Rep is a fully peer-reviewed Journal. Manuscripts should be neatly typed, single-spaced throughout, including tables, graphs, figures.The editors reserve the right to make editorial changes in all matter published in the journal and cannot enter into correspondence about papers not accepted for publication.

Int J Med Rev Case Rep uses Plagiarism Detection Software – iThenticate


Automated Grammar Checker - Grammarly

iThenticate is a plagiarism screening service that verifies the originality of content submitted before publication. iThenticate checks submissions against millions of published research papers, and billions of web content. Authors, researchers and freelancers can also use iThenticate to screen their work before submission by visiting www.ithenticate.com.

International Journal of Medical Reviews and Case Reports (Int J Med Rev Case Rep) accepts manuscripts electronically through Online Journal Management System - eJManager.

The manuscript should be submitted in MS word document through online submission portal or LATEX file by email.

Minimum requirements for images: at least 150 dpi.

You must not put your affiliations or name of the department/hospital in the parts of your manuscipt - (Introduction, Material and methods, Results, Discussion and Conclusion) in order to keep double-blind peer review type of the journal.


Review Articles of specialized topics within the scope of the journal. The maximum length allowed will be 3,000 words, not including the abstract (max. 250 words) or the references. Authors who plan to submit reviews to the journal are advised to contact the review editor Cvetanka Hristova at This email address is being protected from spambots. You need JavaScript enabled to view it. to discuss the suitability of the proposed topic.


Point of View Articles on challenged conventional ideas or hypotheses and which could invite further discussion or debate through correspondence or articles in the journal. Authors who plan to submit Point of View Articles to the journal are advised to contact review editor Cvetanka Hristova at This email address is being protected from spambots. You need JavaScript enabled to view it. to discuss the suitability of the proposed topic. The manuscript should not exceed 2000 words with 2 figures and 30 references.


Short Communications reporting on research that has progressed to the stage where preliminary publication is appropriate. The maximum length allowed will be 2,000 words not including abstract (max.250 words) or the references (maximum 12). There should not be more than 2 illustrations (figure/table).


Letter to the Editor will be considered for publication:


  • If they describe interesting observations.
  • The maximum length allowed will be 750 words, 5 references and 1 illustration.
  • A 50-word abstract is required in the submission box for the benefit of potential reviewers. Please do not include the abstract in the manuscript file.
  • Section headings are not be used in the text.


Please note that International Journal of Medical Reviews and Case Reports accept books for review.



E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.


The publication of an article in a peer-reviewed journal is an essential building block in the development of a coherent and respected network of knowledge. It is a direct reflection of the quality of work of the author and the institutions that support them. Peer-reviewed articles support and embody the scientific method. It is therefore important to agree upon standards of expected ethical behavior.

Ethics topics to consider when publishing:

Authorship of the paper: Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study.

Originality and plagiarism: The authors should ensure that they have written entirely original works, and if the authors have used the work and/or words of others, that this has been appropriately cited or quoted.

Data access and retention: Authors may be asked to provide the raw data in connection with a paper for editorial review, and should be prepared to provide public access to such data.

Multiple, redundant or concurrent publication: An author should not in general publish manuscripts describing essentially the same research in more than one journal or primary publication.

Acknowledgement of sources: Proper acknowledgment of the work of others must always be given.

Disclosure and conflicts of interest: All submissions must include disclosure of all relationships that could be viewed as presenting a potential conflict of interest.

All submissions must include Copyright Assignment Form.

Fundamental errors in published works: When an author discovers a significant error or inaccuracy in his/her own published work, it is the author's obligation to promptly notify the journal editor or publisher and cooperate with the editor to retract or correct the paper.

Reporting standards: Authors of reports of original research should present an accurate account of the work performed as well as an objective discussion of its significance.

Hazards and human or animal subjects: Statements of compliance are required if the work involves chemicals, procedures or equipment that have any unusual hazards inherent in their use, or if it involves the use of animal or human subjects.

Use of patient images or case details: Studies on patients or volunteers require ethics committee approval and informed consent, which should be documented in the paper.


If the work involves the use of animal or human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans http://www.wma.net/en/30publications/10policies/b3/index.html; EU Directive 2010/63/EU for animal experiments http://ec.europa.eu/environment/chemicals/lab_animals/legislation_en.htm; Uniform Requirements for manuscripts submitted to Biomedical journals http://www.icmje.org. Authors should include a statement in the manuscript that the study received ethical approval abd that consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed. Evidence of an institutional waiver must be included when necessary.


Int J Med Rev Case Rep believes that to make the best decision on how to deal with a manuscript the journal editor should know about any competing interests that authors may have. We are not aiming to eradicate competing interests as they are almost inevitable. We will not reject papers simply because authors have a competing interest, but these will be declared on the published paper.

A competing interest exists when professional judgement concerning a primary interest (such as patients’ welfare or the validity of research) may be influenced by a secondary interest (such as financial gain or personal relationship). There is nothing inherently unethical about a competing interest but it should be acknowledged and openly stated.

Examples of competing interests include the following: board membership, consultancy, employment, expert testimony grants (including pending), contract research, lectures/other education events, speakers’ bureaux, patents (planned, pending or issued), receipt of equipment or supplies, royalties, stock/stock options/other forms of ownership, additional expenses not included in COIs already specified, other personal or professional relationships that may influence or appear to influence. 

Authors should download and complete a copy of the ICMJE disclosure form, which is available as a PDF at www.icmje.org/coi_disclosure.pdf. They should keep a copy of the form and send a copy to their corresponding author. The corresponding author must insert within the submitted manuscript a summary statement derived from the information provided in the forms. This will be included in the published article. (After publication, the forms must be made available by the corresponding authors on request.)

Competing interests should be included in a statement headed “Competing Interests” at the end of the manuscript file (before the references)


Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis or as an electronic preprint), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article are checked by the originality detection service Cross Check Ithenticate Plagiarism Detection System.


Each author is required to declare his or her individual contribution to the article: all authors must have materially participated in the research and/or article preparation, so roles for all authors should be described. The statement that all authors have approved the final article should be true and included in the disclosure.


This policy concerns the addition, deletion, or rearrangement of author names in the authorship of accepted manuscripts:
Before the accepted manuscript is published in an online issue: Requests to add or remove an author, or to rearrange the author names, must be sent to the Journal Manager from the corresponding author of the accepted manuscript and must include: (a) the reason the name should be added or removed, or the author names rearranged and (b) written confirmation (e-mail, fax, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed. Requests that are not sent by the corresponding author will be forwarded by the Journal Manager to the corresponding author, who must follow the procedure as described above. Note that: (1) Journal Managers will inform the Journal Editors of any such requests and (2) publication of the accepted manuscript in an online issue is suspended until authorship has been agreed.
After the accepted manuscript is published in an online issue: Any requests to add, delete, or rearrange author names in an article published in an online issue will follow the same policies as noted above and result in a corrigendum.


As an author you (or your employer or institution) have certain rights to reuse your work.


The International Journal of Medical Reviews and Case Reports (Int J Med Rev Case Rep) provides immediate open access to its content on the principle that making research open access to the public supports a greater global exchange of knowledge.

Int J Med Rev Case Rep is an Open Access Journal. This means that all content is open access without charge to the user or his/her institution following the Budapest Open Access Initiative (BOAI) definition of open access. 

The costs of publication are covered by a small publication charge, which is payable by authors (or their grant funding body or institution) whose articles are accepted for publication.

For open access articles, permitted third party (re)use is defined by the following Creative Commons user license: 

Creative Commons Attribution-NonCommercial (CC BY-NC)
For non-commercial purposes, lets others distribute and copy the article, and to include in a collective work (such as an anthology), as long as they credit the author(s).


Our online submission system guides you stepwise through the process of entering your article details and uploading your files. The system converts your article files to a single PDF file used in the peer-review process. Editable files (e.g., Word, LaTeX) are required to typeset your article for final publication. All correspondence, including notification of the Editor's decision and requests for revision, is sent by e-mail.

Please note that typesetters will require an editable document format should your article be accepted. For this reason we ask that your initial submissions be made as .doc(x) file types.


International Journal Medical Reviews and Case Reports (Int J Med Rev Case Rep) does not charge article submission from the authors. Int J Med Rev Case Rep charges a publication fee of 70 Euros for authors. There are no colour figure charges.


The editor assigned to a manuscript conducts an initial review. Some manuscripts will be rejected at this stage, others may be rejected with the suggestion that the submission be transferred to another journal. Submissions that pass the initial review are sent to external reviewers (mainly through the aurhors published their articles in pubmed to ensure both accuracy and relevance).

Time to first decision is from 8 to 16 days. After that your manuscripts are sent for revision. The maximum period for revision is 30 days.

You should be aware that addressing reviewer's comments does not necessarily ensure publication, and the decision to publish will depend on the overall rating of your submission. When submitting a revised manuscript, please note that you will be asked to submit both a clean manuscript (with the revisions incorporated) and a revised manuscript (with the revisions highlighted).

This journal uses double-blind review, which means that both the reviewer and author identities are concealed from the reviewers, and vice versa, throughout the review process.


It is important that the file be saved in the native format of the wordprocessor used or LATEX file. The text should be in single-column format. Keep the layout of the text as simple as possible. Most formatting codes will be removed and replaced on processing the article. In particular, do not use the wordprocessor's options to justify text or to hyphenate words. However, do use bold face, italics, subscripts, superscripts etc. When preparing tables, if you are using a table grid, use only one grid for each individual table and not a grid for each row. If no grid is used, use tabs, not spaces, to align columns. The electronic text should be prepared in a way very similar to that of conventional manuscripts.
To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check' functions of your wordprocessor.

Editors check every manuscript for mistakes with automated grammarly check software - (Grammarly).

Follow this order when typing Papers: Title, Authors, Affiliations, Keywords, Abstract, Main text (suitably divided under headings), Acknowledgements, Abbreviations, References and Figure Captions. Do not import the Figures or Tables into your text; they are to be uploaded separately. The corresponding author should be identified with an asterisk and footnote. All other footnotes (except for table footnotes) should be identified with superscript Arabic numbers.


Title. Concise and informative. Titles are often used in information-retrieval systems. Avoid abbreviations and formulae where possible.

Author names and affiliations. Please clearly indicate the given name(s) and family name(s) of each author and check that all names are accurately spelled. Present the authors' affiliation addresses (where the actual work was done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after the author's name and in front of the appropriate address. Provide the full postal address of each affiliation, including the country name and, if available, the e-mail address of each author.

Corresponding author. Clearly indicate who will handle correspondence at all stages of refereeing and publication, also post-publication. Ensure that the e-mail address is given and that contact details are kept up to date by the corresponding author.

Present/permanent address. If an author has moved since the work described in the article was done, or was visiting at the time, a 'Present address' (or 'Permanent address') may be indicated as a footnote to that author's name. The address at which the author actually did the work must be retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.


Ensure that each illustration has a caption. Supply captions separately, not attached to the figure. A caption should comprise a brief title (not on the figure itself) and a description of the illustration. Keep text in the illustrations themselves to a minimum but explain all symbols and abbreviations used.


Please submit tables as editable text and not as images. Number tables consecutively in accordance with their appearance in the text and place any table notes below the table body. Be sparing in the use of tables and ensure that the data presented in them do not duplicate results described elsewhere in the article. Please avoid using vertical rules.


Use nonproprietary names of drugs, devices, and other products, unless the specific trade name of a drug is essential to the discussion.

The generic (nonproprietary) name of a drug is preferred in almost all instances. If it is necessary to include the brand (proprietary or trade) name for reproduction or interpretation of the study, the brand name should be given parenthetically, following the generic name, at first mention in the abstract, text, and each figure or table in which it appears. In addition, the brand name and supplier’s name and location should be given in the Methods section. In the case in which a manuscript is comparing various brands of a single product, or in which an adverse event is described that might be unique to a single brand of product, both the brand name and generic name should appear at first mention and the brand name(s) should be used thereafter.

Authors submitting manuscripts or letters to the editor regarding adverse drug or medical device reactions, reportable diseases, and the like should also report such to the relevant government agency.


Please cite references with Arabic numbers in squared parentheses and list them by the order in which they appear in the text (not in alphabetical order). References should be numbered consecutively in order of their appearance in the text and listed in numerical order. For references to journal articles, include the first 6 authors, followed by "et al" if there are more than 6 authors. The author names are followed by the title (with only the first word capitalized), the abbreviated name of the journal, the year, volume number (without issue number), and page range. Cite the references in the text by the appropriate number e.g. [1], [2, 3], [4-6], [7, 8-10] and the numbers should be within square brackets. Avoid using abstracts as references. Nothing should be italicized. Journal titles should be abbreviated according to the Index Medicus.

For chapters of books that have an editor(s) and individually authored chapters, include the names of the chapter authors, followed by the chapter title, the book editors, the book title, the city of publication, publisher name, year of publication, and chapter page range.

The list of references should only include works that are cited in the text and that have been published or accepted for publication ("in press"). Personal communications or unpublished data cannot be included in the reference list, but they should be mentioned in the text in parentheses including a date. Permission must be submitted when citing a personal communication. A paper published online but not (yet) in print can be cited using the Digital Object Identifier (DOI).

References with correct punctuation should be styled as follows:

Davì S, Lattanzi B, Demirkaya E, Rosina S, Bracciolini G, Novelli A, et al. Toward the development of new diagnostic criteria for macrophage activation syndrome in systemic juvenile ýdiopathic arthritis. Ann Paediatr Rheum 2012; 1:1-7.

Ozen S, Petty RE. Behcet Disease. In: Cassidy JT, Petty RE, Laxer RM, Lindsley CB (eds). Textbook of pediatric rheumatology, 5th edn. Elsevier, Philadelphia, pp 561-567, 2005

Online document
The inside story: a guide to indoor air quality. In: U.S. EPA/Office of Air and Radiation Available via http://www.epa.gov/iaq/pubs/insidestory.html (Accessed 18 December 2011).

If the author is unknown

McGwire owns the mark alone. ESPN.com. 8 Nov. 2008. http://ESPN.SportsZone.com/mlb/news/1998/980908/00833812.html (8 Nov.2008).

Oter S. Assessment of lipid peroxidation and antioxidant enzymes to determine oxidant stress in rat lung induced by hyperbaric oxygen treatment at different doses and intervals. Dissertation, Gulhane Military Medical Academy, Ankara, Turkey, 1998.

Article by DOI (digital object identifier)
Polat A, Demirkaya E, Basbozkurt G, Gattorno M, Ozen S. A glance at history and future perspectives of childhood autoinflammatory disorders. Ann Paediatr Rheum 2012; doi: 10.5455/apr.022120120023


Journal names should be abbreviated according to the List of Title Word Abbreviations: http://www.issn.org/services/online-services/access-to-the-ltwa/.


The Digital Object Identifier (DOI) may be used to cite and link to electronic documents. The DOI consists of a unique alpha-numeric character string which is assigned to a document by the publisher upon the initial electronic publication. The assigned DOI never changes. Therefore, it is an ideal medium for citing a document, particularly 'Articles in press' because they have not yet received their full bibliographic information. Example of a correctly given DOI (in URL format; here an article in the journal Physics Letters B):
When you use a DOI to create links to documents on the web, the DOIs are guaranteed never to change.

As a service to the community, this journal makes available online the accepted manuscripts as soon as possible after acceptance. At this stage, the author's accepted manuscript (in both full-text and PDF) is given a Digital Object Identifier (DOI) and is fully citable, and searchable by title, author(s) name and the full-text. The article also carries a disclaimer noting that it is an unedited manuscript which has not yet been copyedited, typeset or proofread. When the fully copyedited version is ready for publication, it simply replaces the author accepted manuscript version.


The International Journal of Medical Reviews and Case Reports provides a waiver of Article Processing Charges to authors based in any of the following countries which were classified by the World Bank as Low-income economies as of July 2018.

Authors from Low Income Countries may be granted up to 70% waiver.


In order to apply for a waiver, please request one before submitting your manuscript by sending an email to inkov@journalmedicalreports.com

List of Low-income Countries:


Digital Archive Policy

All journal content issues are digital self-archived in the National Library of Sofia, Bulgaria.